FORT WORTH, Texas, Oct. 12 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc. a rapidly growing provider of specialty medical products, announced today that its subsidiary Wound Care Innovations, LLC has launched the Cifra(TM) healthcare platform to securely exchange and store information for ongoing evidence based case studies on its patented collagen CellerateRx(R) products in managing all types of wound care.
Cathy Bradshaw, president of Wound Care Innovations, said, “We are working with physicians and healthcare specialists who are treating thousands of patients every day for various types of skin wounds. As part of that activity, we are compiling evidence based studies confirming the effectiveness of our patented collagen CellerateRx(R) products. The Cifra platform is a vital tool in providing secure messaging and document delivery. Also of importance is its ability to provide both secure storage and backup. This outstanding level of security means that participants can collaborate and work together while maintaining stringent HIPAA mandated compliance and patient confidentiality.”
Wound Management Technologies CEO, Scott Haire said, “Although Wound Care Innovations will initially use Cifra within our own organization and physician community, we also have the rights to license the Cifra platform to vendors, partners and other health care community associates. In the next phase of implementation, Cifra will introduce the Secure eHealth System Tray Notifier(TM), which will add the capability to send secure notification alerts to enrolled users. With this additional function, we will ensure a truly secure medical community for all participants.”
For more information about Secure eHealth go to www.secure-ehealth.com
For more information about Wound Care Innovations go to www.celleraterx.com
About Cifra
Cifra is a secure communication and storage software platform developed by DRM Security, LLC and licensed to Secure eHealth that allows customers to securely store and share any type of digital file. Cifra accomplishes this functionality using technology that allows the originating user to specify document rights (viewing, editing, copying, printing, commenting) for the recipient within the closed network design. This can be revoked or changed at any time even while a recipient is viewing the content on his own screen. Cifra’s secure viewer allows the sender to share virtually any file type without that file ever being saved to the recipient’s computer. Cifra allows users to store encrypted files on a secure server. This robust application also provides instant chat messaging with other users within a highly secure environment.
About Wound Management Technologies, Inc.:
Wound Management Technologies, through its subsidiary Wound Care Innovations, markets and distributes wound care products to the healthcare market under patented technology licensed to the company. The company is positioned and seeks to be a leading provider of wound care products. The company’s corporate headquarters are in Fort Worth, Texas, For more information please visit the company’s website at www.celleraterx.com.
An online investor kit including press releases, current price quotes, stock charts and other valuable information for investors may be found at www.hawkassociates.com.
A profile for investors can be accessed at http://www.hawkassociates.com/clients/profile/wnmd.cfm.
To receive free e-mail notification of future releases for Wound Management, sign up at www.hawkassociates.com/about/alert/.
Safe Harbor Statement Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company’s expectations with regard to the future impact on the company’s results from new products in development are “forward-looking statements,” within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company’s actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company’s operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company’s SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.
Contacts:
Product information contact Cathy Bradshaw at 954-315-9242.
Shareholder relations, contact Lucy Singleton at 817-820-7080.
Investor relations information, contact Frank Hawkins or Julie Marshall, Hawk Associates, at 305-451-1888 or email woundcare@hawkassociates.com.
SOURCE Wound Management Technologies, Inc.
CONTACT: Product information: Cathy Bradshaw, +1-954-315-9242; Shareholder
relations: Lucy Singleton, +1-817-820-7080; Investor relations: Frank
Hawkins or Julie Marshall, Hawk Associates, +1-305-451-1888,
woundcare@hawkassociates.com
Web site: http://www.celleraterx.com/
